Sex steroids and glucose metabolism.
Testosterone levels are lower in men with metabolic syndrome and type 2 diabetes mellitus (T2DM) and also predict the onset of these adverse metabolic states. Body composition (body mass index, waist circumference) is an important mediator of this relationship. Sex hormone binding globulin is also inversely associated with insulin resistance and T2DM but the data regarding estrogen are inconsistent. Clinical models of androgen deficiency including Klinefelter's syndrome and androgen deprivation therapy in the treatment of advanced prostate cancer confirm the association between androgens and glucose status. Experimental manipulation of the insulin/glucose milieu and suppression of endogenous testicular function suggests the relationship between androgens and insulin sensitivity is bidirectional. Androgen therapy in men without diabetes is not able to differentiate the effect on insulin resistance from that on fat mass, in particular visceral adiposity. Similarly, several small clinical studies have examined the efficacy of exogenous testosterone in men with T2DM, however, the role of androgens, independent of body composition, in modifying insulin resistance is uncertain.
Prince Henry's Institute, Clayton,; Monash Health, Clayton; Department of Obstetrics and Gynaecology, Monash University, Clayton; Andrology Australia, c/o School of Public Health and Preventive Medicine, Monash University, Prahran, Australia.
Carolyn A
CA
Allan
D003924:Diabetes Mellitus, Type 2 / Q000097:blood; D004967:Estrogens / Q000502:physiology; D005947:Glucose / Q000378:metabolism*; D020249:Hormone Replacement Therapy; D006801:Humans; D007333:Insulin Resistance; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood; D012738:Sex Hormone-Binding Globulin / Q000502:physiology; D013739:Testosterone / Q000008:administration & dosage / Q000097:blood / Q000502:physiology*
D004967:Estrogens; D012738:Sex Hormone-Binding Globulin; D013739:Testosterone; D005947:Glucose